K. Steven LaForge

Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: Possible implications for opiate addiction

Cherie E. Bond, K. Steven LaForge, Mingting Tian et al. · Proceedings of the National Academy of Sciences · 1998 · 1.1K citations

Medicine, Molecular Genetics, Pharmacology +17

On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion.

Anuradha Ray, K. Steven LaForge, Pravinkumar B. Sehgal · Molecular and Cellular Biology · 1990 · 279 citations

Life Sciences, Molecular Biology, Molecular Genetics +17

Increased Attributable Risk Related to a Functional μ-Opioid Receptor Gene Polymorphism in Association with Alcohol Dependence in Central Sweden

Gavin Bart, Mary Jeanne Kreek, Jürg Ott et al. · Neuropsychopharmacology · 2004 · 222 citations

Medicine, Molecular Genetics, Pharmacology +17

The single nucleotide polymorphism A118G alters functional properties of the human mu opioid receptor

Thomas Kroslak, K. Steven LaForge, Robert Gianotti et al. · Journal of Neurochemistry · 2007 · 215 citations

Medicine, Molecular Genetics, Pharmacology +17

Differential gene expression in the rat caudate putamen after “binge” cocaine administration: Advantage of triplicate microarray analysis

Vadim Yuferov, Thomas Kroslak, K. Steven LaForge et al. · Synapse · 2003 · 142 citations

Life Sciences, Genetics, Molecular Biology +15